Displaying 1 - 1 of 1
| Active Ingredient | EPIRUBICIN |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Acute leukaemias, lymphomas, solid tumours. |
| Caution | Leukopenia, nausea and vomiting, diarrhoea, thrombocytopenia, EKG changes, congestive cardiac failure secondary to a diffuse cardiomyopathy, alopecia. C.f. prescribing in liver disease p. 13. |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | Avoid during pregnancy. Teratogenic effects and embryotoxicity were noted in ani More ... |
| Breast Feeding | It is unknown whether epirubicin is distributed in milk. Breastfeeding is theref More ... |